Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The gene KAP22-1 affects wool yield and fiber shape in sheep.

Eruptive vellus hair cysts are a cosmetic skin condition, more common in young adults, with few effective treatments.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Over 67 genes linked to ichthyosis help improve diagnosis and treatment.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

DNA phenotyping helps predict physical traits from DNA with varying accuracy and requires careful ethical and legal handling.

Higher DHT in male baldness may protect against prostate cancer.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Dynamic, light touch is sensed through a common mechanism involving Piezo2 channels in sensory axons.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.